Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.

Publication ,  Journal Article
Bleeker, G; van Eck-Smit, BL; Zwinderman, KH; Versteeg, R; van Noesel, MM; Kam, BL; Kaspers, GJ; van Schie, A; Kreissman, SG; Yanik, G; Hero, B ...
Published in: Eur J Nucl Med Mol Imaging
February 2015

PURPOSE: The aim of this study was to find clinically relevant MIBG-avid metastatic patterns in patients with newly diagnosed stage 4 neuroblastoma. METHODS: Diagnostic (123)I-MIBG scans from 249 patients (123 from a European and 126 from the COG cohort) were assessed for metastatic spread in 14 body segments and the form of the lesions: "focal" (clear margins distinguishable from adjacent background) or "diffuse" (indistinct margins, dispersed throughout the body segment). The total numbers of diffuse and focal lesions were recorded. Patients were then categorized as having lesions exclusively focal, lesions more focal than diffuse, lesions more diffuse than focal, or lesions exclusively diffuse. RESULTS: Diffuse lesions affected a median of seven body segments and focal lesions a median of two body segments (P < 0.001, both cohorts). Patients with a focal pattern had a median of 2 affected body segments and those with a diffuse pattern a median of 11 affected body segments (P < 0.001, both cohorts). Thus, two MIBG-avid metastatic patterns emerged: "limited-focal" and "extensive-diffuse". The median numbers of affected body segments in MYCN-amplified (MNA) tumours were 5 (European cohort) and 4 (COG cohort) compared to 9 and 11, respectively, in single-copy MYCN (MYCNsc) tumours (P < 0.001). Patients with exclusively focal metastases were more likely to have a MNA tumour (60% and 70%, respectively) than patients with the other types of metastases (23% and 28%, respectively; P < 0.001). In a multivariate Cox regression analysis, focal metastases were associated with a better event-free and overall survival than the other types of metastases in patients with MNA tumours in the COG cohort (P < 0.01). CONCLUSION: Two metastatic patterns were found: a "limited and focal" pattern found mainly in patients with MNA neuroblastoma that correlated with prognosis, and an "extensive and diffuse" pattern found mainly in patients with MYCNsc neuroblastoma.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur J Nucl Med Mol Imaging

DOI

EISSN

1619-7089

Publication Date

February 2015

Volume

42

Issue

2

Start / End Page

222 / 230

Location

Germany

Related Subject Headings

  • Tomography, X-Ray Computed
  • Radiopharmaceuticals
  • Prognosis
  • Predictive Value of Tests
  • Positron-Emission Tomography
  • Oncogene Proteins
  • Nuclear Proteins
  • Nuclear Medicine & Medical Imaging
  • Neuroblastoma
  • Neoplasm Metastasis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bleeker, G., van Eck-Smit, B. L., Zwinderman, K. H., Versteeg, R., van Noesel, M. M., Kam, B. L., … Tytgat, G. A. (2015). MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. Eur J Nucl Med Mol Imaging, 42(2), 222–230. https://doi.org/10.1007/s00259-014-2909-1
Bleeker, Gitta, Berthe L. van Eck-Smit, Koos H. Zwinderman, Rogier Versteeg, Max M. van Noesel, Boen L. Kam, Gertjan J. Kaspers, et al. “MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.Eur J Nucl Med Mol Imaging 42, no. 2 (February 2015): 222–30. https://doi.org/10.1007/s00259-014-2909-1.
Bleeker G, van Eck-Smit BL, Zwinderman KH, Versteeg R, van Noesel MM, Kam BL, et al. MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):222–30.
Bleeker, Gitta, et al. “MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.Eur J Nucl Med Mol Imaging, vol. 42, no. 2, Feb. 2015, pp. 222–30. Pubmed, doi:10.1007/s00259-014-2909-1.
Bleeker G, van Eck-Smit BL, Zwinderman KH, Versteeg R, van Noesel MM, Kam BL, Kaspers GJ, van Schie A, Kreissman SG, Yanik G, Hero B, Schmidt M, Laureys G, Lambert B, Øra I, Schulte JH, Caron HN, Tytgat GA. MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):222–230.
Journal cover image

Published In

Eur J Nucl Med Mol Imaging

DOI

EISSN

1619-7089

Publication Date

February 2015

Volume

42

Issue

2

Start / End Page

222 / 230

Location

Germany

Related Subject Headings

  • Tomography, X-Ray Computed
  • Radiopharmaceuticals
  • Prognosis
  • Predictive Value of Tests
  • Positron-Emission Tomography
  • Oncogene Proteins
  • Nuclear Proteins
  • Nuclear Medicine & Medical Imaging
  • Neuroblastoma
  • Neoplasm Metastasis